← FDA Drug Approvals (Drugs@FDA)

TAGAMET HB 200

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1999-07-09

Drug application

FDA Application #

NDA020951

Application type

New Drug Application

Brand name

TAGAMET HB 200

Generic name

Cimetidine

Active ingredients

CIMETIDINE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Discontinued

Sponsor

GLAXOSMITHKLINE

First approval

1999-07-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown